Profile data is unavailable for this security.
About the company
Shanghai Serum Bio-Technology Co Ltd is a China-based company mainly engaged in the research and development of antisera and antitoxins. The Company is mainly engaged in the research, development, manufacturing and sales of preventive and therapeutic drugs in the field of biotoxins and biosafety. The Company's main products include anti-pit viper venom, anti-five-step snake venom, anti-bungi venom, anti-cobra venom, equine immunoglobulin and anti-rabies serum. The Company's products are mainly used for emergency snakebite treatment. The Company mainly conducts its businesses in the domestic market.
- Revenue in CNY (TTM)194.44m
- Net income in CNY44.17m
- Incorporated1999
- Employees321.00
- LocationShanghai Serum Bio-Technology Co LtdNo. 1288, Huaqing Road, Qingpu DistrictSHANGHAI 201707ChinaCHN
- Phone+86 2 164959122
- Fax+86 2 164959122
- Websitehttp://www.serum-china.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jiangsu gdk Biotechnology Co Ltd | 10.74m | -146.94m | 1.63bn | 451.00 | -- | 1.22 | -- | 151.35 | -1.19 | -1.19 | 0.0871 | 10.80 | 0.0064 | 0.1697 | 0.0778 | 23,806.61 | -8.73 | 3.30 | -10.20 | 4.84 | -1.88 | 75.56 | -1,368.55 | 12.58 | 3.10 | -- | 0.0412 | 32.60 | -57.74 | -- | -270.88 | -- | 54.07 | -- |
Shanghai Serum Bio-Technology Co Ltd | 194.44m | 44.17m | 1.93bn | 321.00 | 43.63 | 1.76 | -- | 9.91 | 0.4082 | 0.4082 | 1.80 | 10.13 | 0.1738 | 1.03 | 3.49 | 605,741.10 | 3.95 | 10.43 | 4.02 | 10.84 | 75.64 | 80.54 | 22.72 | 32.57 | 49.77 | -- | 0.0114 | 64.93 | 9.14 | 5.67 | -39.54 | -1.62 | 13.07 | -- |
Shanghai Shen Lian Biomedical Corp | 304.79m | -12.92m | 1.99bn | 380.00 | -- | 1.38 | -- | 6.53 | -0.0315 | -0.0315 | 0.7422 | 3.51 | 0.196 | 0.9229 | 1.15 | 802,082.80 | -1.06 | 5.39 | -1.12 | 5.84 | 64.36 | 77.45 | -5.42 | 25.48 | 5.16 | -- | 0.0015 | 38.49 | -8.25 | 1.85 | -48.41 | -18.49 | 10.47 | -- |
Hanshang Group Co Ltd | 1.31bn | 21.51m | 2.21bn | 2.38k | 98.97 | 1.29 | -- | 1.68 | 0.0757 | 0.0757 | 4.46 | 5.83 | 0.3718 | 2.65 | 8.25 | 552,235.40 | 0.3729 | 2.00 | 0.6192 | 3.89 | 55.85 | 57.24 | 1.00 | 4.89 | 0.2774 | 1.84 | 0.3798 | 15.03 | 0.1893 | 5.14 | -32.24 | 25.62 | 12.88 | -- |
Data as of Oct 11 2024. Currency figures normalised to Shanghai Serum Bio-Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.15m | 4.64% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 1.13m | 4.55% |
Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 675.10k | 2.73% |
Goldstate Capital Fund Management Co., Ltd.as of 31 Dec 2023 | 409.90k | 1.66% |
Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 134.04k | 0.54% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 120.00k | 0.49% |
Orient Fund Management Co., Ltd.as of 31 Dec 2023 | 47.87k | 0.19% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 39.87k | 0.16% |
Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 34.40k | 0.14% |
Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 25.57k | 0.10% |
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.